BPTH
BIO-PATH HOLDINGS INC by Bio-Path Holdings, Inc. (BPTH)
$00
About BIO-PATH HOLDINGS INC by Bio-Path Holdings, Inc. (BPTH)
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1001-A, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.
Details
Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.11
52 Week Low
$0.00
Market cap
10,100
Dividend yield
-
Volume
145
Avg. volume
70,559
P/E ratio
.00
BIO-PATH HOLDINGS INC by Bio-Path Holdings, Inc. News
Details
Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.11
52 Week Low
$0.00
Market cap
10,100
Dividend yield
-
Volume
145
Avg. volume
70,559
P/E ratio
.00